Sulfur Dioxide: An Endogenous Protector Against Myocardial Injury. Issue 4 (October 2020)

• Record Type: Journal Article
• Authors: Zhou, Dan; Zhang, Yong; Du, Junbao; Jin, Hongfang; Tang, Chaoshu; Huang, Yaqian
• Is Part Of: Journal of cardiovascular pharmacology. Volume 76:Issue 4(2020)
• Publication Date: 2020-10
• Subjects: sulfur dioxide -- myocardial injury -- oxidative stress -- anti-inflammatory -- endoplasmic reticulum stress; Cardiovascular Diseases -- drug therapy -- Periodicals; Cardiovascular System -- drug effects -- Periodicals; Cardiovascular pharmacology -- Periodicals; Cardiovascular agents -- Periodicals; Cardiovascular agents; Cardiovascular pharmacology; Periodicals; 615.7105
• DOI: 10.1097/FJC.0000000000000882
• Languages: English
• ISSNs: 0160-2446

Abstract

Abstract : Abstract: Sulfur dioxide (SO2 ) was previously known as a harmful gas in air pollution. Recently, it was reported that SO2 can be endogenously generated in cardiovascular tissues. Many studies have revealed that endogenous SO2 has important physiological and pathophysiological significance and pharmacological potential. As a novel gasotransmitter, SO2 has important regulatory effects on the heart. It has a dose-dependent negative inotropic effect on cardiac function, in which L-type calcium channels are involved. SO2 can also attenuate myocardial injury caused by various harmful stimuli and play an important role in myocardial ischemia-reperfusion injury and myocardial hypertrophy. These effects are thought to be linked to its ability to reduce inflammation and as an antioxidant. In addition, SO2 regulates cardiomyocyte apoptosis and autophagy. Therefore, endogenous SO2 plays an important role in maintaining cardiovascular system homeostasis. In the present review, the literature concerning the metabolism of endogenous SO2, its cardiac toxicological effects and physiological regulatory effects, mechanisms for SO2 -mediated myocardial protection and its pharmacological applications are summarized and discussed.